TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. By Cancer History Project October 15, 2004
TCL Archive Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual. By Cancer History Project October 15, 2004
TCL Archive Hope for FDA authority over tobacco products dies in Congress. By Cancer History Project October 15, 2004
TCL Archive Patients urge Medicare to allow an open formulary for cancer treatment. By Cancer History Project October 15, 2004
TCL Archive Promotions at MSKCC: Fuks heads radiation oncology, Pfister named chief of Head & Neck Medical Oncology Service. By Cancer History Project October 15, 2004
TCL Archive New guidelines for Cancer Center Support Grants will enable centers to apply for salary support for clinical investigators. By Cancer History Project October 8, 2004
TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. By Cancer History Project October 8, 2004
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
